CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended		116 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012
Cash flows from operating activities
Net loss	$ (6,896,479)	$ (4,091,439)	$ (107,577,266)
Adjustments to reconcile net loss to net cash used in operating activities
Stock payable for acquired research and development			112,440
Stock issued for acquired research and development			26,286,589
Stock issued for services		87,028	2,061,743
Stock issued for debt in excess of principal			109,070
Amortization of discount on notes payable due to warrants and beneficial conversion feature	34,600		6,787,298
Gain on extinguishment of debt			(1,612,440)
Depreciation	225,365	157,254	1,571,846
Amortization of debt financing costs	24,710		549,088
Option expense	542,766	385,811	16,117,973
Gain on derivative instruments	136,889		(1,251,959)
Loss on disposition of fixed assets		413	510,248
Changes in:
Other current assets	(1,025,807)	(20,120)	(1,567,253)
Accounts payable - third parties and related parties	(130,278)	59,817	(219,519)
Accrued expenses	(219,372)	(49,976)	302,848
Net cash used in operating activities	(7,307,606)	(3,471,212)	(57,819,294)
Cash flows from investing activities
Purchase of property & equipment	(512,048)	(284,017)	(2,183,858)
Restricted cash	(1,000,000)		(1,000,000)
Net cash used in investing activities	(1,512,048)	(284,017)	(3,183,858)
Cash flows from financing activities
Common stock and warrants sold for cash, net of offering costs		8,618,157	49,072,488
Convertible promissory notes and warrants sold for cash, net of offering costs
Common stock repurchased and canceled			(325)
Proceeds from exercise of warrants and options			1,248,588
Proceeds from third party debt	3,455,000		12,738,184
Proceeds from related party debt	630,000		630,000
Debt financing costs	(136,943)		(136,943)
Repayments on notes payable		(35,607)	(311,222)
Net cash provided by financing activities	3,948,057	8,582,550	63,240,770
Net change in cash and cash equivalents	(4,871,597)	4,827,321	2,237,618
Cash and cash equivalents at beginning of period	7,109,215	3,812,535
Cash and cash equivalents at end of period	2,237,618	8,639,856	2,237,618
Cash paid for:
Income tax
Interest	1,460	2,643	154,623
NON-CASH TRANSACTIONS
Issuance of common stock to Sportan shareholders			147,733
Issuance of common stock for accrued interest			603,604
Issuance of warrants to placement agent			37,453
Conversion of notes payable to common stock			7,709,980
Conversion of accrued liabilities to common stock			197,176
Conversion of accounts payable to note payable			93,364
Discount on convertible notes relating to:
Warrants	2,314,635		5,974,372
Beneficial conversion feature	1,497,634		3,303,153
Stock attached to notes			1,287,440
Fair value of derivative instrument			4,680,220
Derivative reclassified to equity			587,609
Unpaid additions to property and equipment	11,730	10,911	11,730
Unpaid additions to deferred financing costs	$ 170,831		$ 170,831